MedicineNews

Researchers One Step Closer to Find Cure for HIV – Using Combination of CRISPR and LASER ART Eliminated HIV DNA from Live Mice

Researchers say they’re one step closer to discovering a possible cure for HIV after successfully eliminating the virus in live mice for the first time.

Using a combination of CRISPR gene-editing technology and a therapeutic remedy referred to as LASER ART, scientists at the Temple University and the University of Nebraska Medical Center mentioned they eradicated HIV DNA from the genomes of animals in what they name an unprecedented study that was published Tuesday within the journal Nature Communications.

We predict this study is a serious breakthrough as a result of it for the first time demonstrates after 40 years of the AIDS epidemic that the HIV disease is a curable disease, stated study co-author Dr. Kamel Khalili, chair of the department of neuroscience and director of the Center for Neurovirology and the Comprehensive NeuroAIDS Center at Temple University.

The virus is at present treated with antiretroviral therapy (ART), which suppresses it from replicating and prevents many patients within the U.S. from developing AIDS. ART doesn’t rid the body of HIV, although, and if a patient stops therapy, the virus will advance to replicate.

The study authors used two completely different instruments to fight the virus: CRISPR technology and LASER ART.

CRISPR-Cas9 is a gene-editing tool that’s been boasted as breakthrough expertise that may assist researchers to treat or doubtlessly cure genetic diseases. It offers scientists the flexibility to alter an organism’s DNA, to allow them to add, take away, or change certain genetic materials.

LASER ART is a “super” type of ART that retains replication of the virus at low levels for more extended periods, according to co-author Dr. Howard Gendelman, chairman of UNMC’s pharmacology and experimental neuroscience division and director of the Center for Neurodegenerative Diseases. The antiretroviral drug is then stocked in nanocrystals, which slowly launch the drug the place the virus is positioned.

The virus didn’t return in nine of the 21 mice wherein the strategy was examined, in line with Khalili.

The study authors say the discovery is promising and they’re now testing the CRISPR-LASER ART combination on primates. Nonetheless, there’s; however, much work that must be accomplished earlier than the method will be tested on humans.

Although the examine was performed on mice, Gendelman mentioned it’s nonetheless vital as a result of it exhibits that sterilization of HIV in living animals is possible.

Tags

Nicholas Shorts

Nicholas leads the Pharma column. He is an excellent writer and a team leader with five years’ experience in medical writing. Nicholas is a Journalism degree holder from Texas A&M University. Before taking up Medical literature, he was a Journalism professor. Nicholas is also a poet.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close